Single DMT Dose Shows Rapid Antidepressant Effects Lasting Three Months
Phase IIa trial finds intravenous DMT with therapy support significantly reduces depression symptoms within 2 weeks.
6405 articles
Phase IIa trial finds intravenous DMT with therapy support significantly reduces depression symptoms within 2 weeks.
Clinical trials reveal green tea catechins can reduce visceral fat by over 6% in 12 weeks through a simple daily routine.
Researchers argue neurodegenerative disease trials need better biological understanding to improve treatment success rates.
Siim Land breaks down the most impactful health factors based on mortality data, from VO2 max to visceral fat targets.
New research reveals how tumors reprogram neutrophils to produce CCL3, turning immune defenders into cancer allies.
Small pilot study examined psilocybin's effects on brain circuits and emotion processing in healthy adults to understand abuse potential.
Scientists created muscle organoids from patient cells that show gene therapy improves muscle function but fails to stop harmful scarring.
New research reveals that robust insulin production after eating actually reduces disease risk, contrary to popular belief.
WHO-commissioned reviews find Ozempic and similar drugs deliver up to 16% weight loss, but long-term safety data remains limited.
French pilot study tests psychedelic therapy for patients with alcohol use disorder and comorbid depression after withdrawal.
New research reveals how stretching forces activate stem cells and immune cells to rebuild facial bone structure through collagen remodeling.
New research reveals optimal sauna protocols for cardiovascular health, longevity, and performance enhancement.